Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-02 12:38 pm Purchase |
2022-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
STATE STREET CORP STT |
552,469 7.320% |
184,890 (+50.30%) |
Filing History |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
BlackRock Inc. BLK |
567,216 10.500% |
0 (Unchanged) |
Filing History |
| 2023-01-20 5:17 pm Sale |
2022-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
BlackRock Inc. BLK |
567,216 10.500% |
-27,331 (-4.60%) |
Filing History |
| 2022-12-08 10:22 am Purchase |
2022-12-05 | 13G | Karyopharm Therapeutics Inc. KPTI |
Avidity Partners Management LP | 756,788 9.900% |
756,788 (New Position) |
Filing History |
| 2022-05-09 4:30 pm Purchase |
2022-04-27 | 13G | Karyopharm Therapeutics Inc. KPTI |
Commodore Capital LP | 267,403 5.100% |
267,403 (New Position) |
Filing History |
| 2022-02-14 5:09 pm Purchase |
2021-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Palo Alto Investors LP | 364,697 7.240% |
13,520 (+3.85%) |
Filing History |
| 2022-02-11 4:01 pm Sale |
2021-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Kauffman Michael | 271,888 5.200% |
-10,209 (-3.62%) |
Filing History |
| 2022-02-11 2:54 pm Sale |
2021-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Chione Ltd. | 333,333 6.600% |
-33,333 (-9.09%) |
Filing History |
| 2022-02-11 08:38 am Sale |
2021-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
STATE STREET CORP STT |
367,579 7.300% |
-167,088 (-31.25%) |
Filing History |
| 2022-01-27 5:13 pm Unchanged |
2021-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
BlackRock Inc. BLK |
594,547 11.800% |
0 (Unchanged) |
Filing History |
| 2022-01-26 09:16 am Purchase |
2021-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
BlackRock Inc. BLK |
594,547 11.800% |
96,207 (+19.31%) |
Filing History |
| 2021-10-12 12:23 pm Purchase |
2021-09-30 | 13G | Karyopharm Therapeutics Inc. KPTI |
STATE STREET CORP STT |
534,667 10.620% |
178,676 (+50.19%) |
Filing History |
| 2021-02-17 3:12 pm Sale |
2020-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Consonance Capital Management LP | 0 0.000% |
-403,900 (Position Closed) |
Filing History |
| 2021-02-16 4:41 pm Purchase |
2020-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Palo Alto Investors LP | 351,177 7.160% |
44,843 (+14.64%) |
Filing History |
| 2021-02-16 4:35 pm Purchase |
2020-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Kauffman Michael | 282,097 5.510% |
20,668 (+7.91%) |
Filing History |
| 2021-02-16 4:03 pm Sale |
2020-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Chione Ltd. | 366,667 7.500% |
-13,033 (-3.43%) |
Filing History |
| 2021-02-16 2:21 pm Sale |
2020-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Consonance Capital Management LP | 403,900 11.000% |
-4,595 (-1.12%) |
Filing History |
| 2021-02-12 08:13 am Sale |
2020-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
AVORO CAPITAL ADVISORS LLC | 0 0.000% |
-393,333 (Position Closed) |
Filing History |
| 2021-02-11 3:09 pm Purchase |
2020-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
STATE STREET CORP STT |
355,991 7.260% |
140,766 (+65.40%) |
Filing History |
| 2021-02-11 08:19 am Sale |
2020-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
ADAGE CAPITAL PARTNERS GP L.L.C. | 164,333 3.350% |
-88,133 (-34.91%) |
Filing History |